TIAA CREF Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $28.4M | Buy |
2,083,163
+910,610
| +78% | +$12.4M | 0.02% | 574 |
|
|
2018
Q4 | $10.6M | Buy |
1,172,553
+4,797
| +0.4% | +$43.4K | 0.01% | 925 |
|
|
2018
Q3 | $19.3M | Buy |
1,167,756
+29,474
| +3% | +$486K | 0.01% | 754 |
|
|
2018
Q2 | $15.9M | Buy |
1,138,282
+71,392
| +7% | +$999K | 0.01% | 870 |
|
|
2018
Q1 | $11.8M | Buy |
1,066,890
+23,895
| +2% | +$264K | 0.01% | 1026 |
|
|
2017
Q4 | $9.18M | Buy |
1,042,995
+12,313
| +1% | +$108K | 0.01% | 1194 |
|
|
2017
Q3 | $13.8M | Buy |
1,030,682
+29,578
| +3% | +$395K | 0.01% | 953 |
|
|
2017
Q2 | $14.4M | Buy |
1,001,104
+414,229
| +71% | +$5.94M | 0.01% | 920 |
|
|
2017
Q1 | $12.4M | Buy |
586,875
+308,332
| +111% | +$6.52M | 0.01% | 985 |
|
|
2016
Q4 | $7.84M | Sell |
278,543
-185,371
| -40% | -$5.22M | 0.01% | 1292 |
|
|
2016
Q3 | $12.4K | Sell |
463,914
-261,208
| -36% | -$7K | 0.01% | 992 |
|
|
2016
Q2 | $12.2M | Buy |
725,122
+5,669
| +0.8% | +$95.7K | 0.01% | 950 |
|
|
2016
Q1 | $15.3M | Sell |
719,453
-19,646
| -3% | -$417K | 0.01% | 847 |
|
|
2015
Q4 | $17M | Sell |
739,099
-18,780
| -2% | -$431K | 0.01% | 820 |
|
|
2015
Q3 | $15.2M | Sell |
757,879
-1,335
| -0.2% | -$26.8K | 0.01% | 843 |
|
|
2015
Q2 | $21.9M | Buy |
759,214
+703,096
| +1,253% | +$20.3M | 0.02% | 755 |
|
|
2015
Q1 | $1.72M | Buy |
56,118
+54,595
| +3,585% | +$1.67M | ﹤0.01% | 2318 |
|
|
2014
Q4 | $25K | Buy |
+1,523
| New | +$25K | ﹤0.01% | 3136 |
|